Taipei City Psychiatric Center, Taipei City Hospital, Taipei, Taiwan.
School of Gerontology Health Management, College of Nursing, Taipei Medical University, Taipei, Taiwan; Psychiatric Research Center, Taipei Medical University Hospital, Taipei, Taiwan; Department of Nursing, Taipei Medical University-Shuang Ho Hospital, Taipei, Taiwan; Graduate Institutes of Nursing, College of Nursing, Taipei Medical University, Taipei, Taiwan.
Behav Res Ther. 2015 Oct;73:143-50. doi: 10.1016/j.brat.2015.07.016. Epub 2015 Aug 1.
We evaluated the effects of cognitive behavioral therapy for insomnia (CBT-I) in inpatients with a diagnosis of depression and comorbid insomnia.
This study used a prospective, parallel-group design. The experimental group received CBT-I for no more than 90 min once weekly for 6 weeks and the control group only have health education manuals for insomnia. The following questionnaires were administered at baseline: the Hamilton Rating Scale for Depression (HAM-D), Dysfunctional Beliefs and Attitudes about Sleep (DBAS), Presleep Arousal Scale (PSAS), Sleep Hygiene Practice (SHP), and Pittsburgh Sleep Quality Index. The questionnaires were readministered after the completion of the 6-wk CBT-I intervention and 1 month following the completion of CBT-I, to determine the effects of the CBT-I intervention over time. The analysis of Generalized Estimation Equations was identified the difference between the experimental group and the control group by controlling for the variables in BZD dose and propensity score of gender, age, and the scores for the DBAS-16, PSAS, SHPS, and HAM-D.
Consequently, the significant difference in the PSQI scores was observed at the 1-month follow-up assessment however, no significant intergroup difference in the PSQI scores was found at the completion of the CBT-I intervention between two groups.
As a conclusion, we found that overall sleep quality significantly improved in patients who received CBT-I after we controlled for the BZD dose and propensity score, which suggests that CBT-I may represent a useful clinical strategy for improving sleep quality in patients with depression and comorbid insomnia.
我们评估了认知行为疗法治疗伴有失眠共病的抑郁症住院患者的效果。
本研究采用前瞻性平行组设计。实验组每周接受一次不超过 90 分钟的认知行为疗法治疗,为期 6 周,对照组仅提供失眠健康教育手册。在基线时,使用以下问卷进行评估:汉密尔顿抑郁量表(HAM-D)、睡眠障碍信念和态度量表(DBAS)、入睡前唤醒量表(PSAS)、睡眠卫生习惯量表(SHP)和匹兹堡睡眠质量指数(PSQI)。在完成 6 周认知行为疗法干预后和完成认知行为疗法后 1 个月再次进行问卷调查,以确定认知行为疗法干预的时间效应。通过控制 BZD 剂量和性别、年龄的倾向评分以及 DBAS-16、PSAS、SHPS 和 HAM-D 的得分,广义估计方程分析确定了实验组和对照组之间的差异。
因此,在 1 个月的随访评估中观察到 PSQI 评分的显著差异,但在完成认知行为疗法干预时,两组之间 PSQI 评分无显著组间差异。
总之,我们发现,在控制 BZD 剂量和倾向评分后,接受认知行为疗法的患者的总体睡眠质量显著改善,这表明认知行为疗法可能是改善伴有失眠共病的抑郁症患者睡眠质量的一种有用的临床策略。